NCT04665206 2026-04-02
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
Vivace Therapeutics, Inc
Phase 1/2 Recruiting
Vivace Therapeutics, Inc
AstraZeneca
iOnctura
University Hospital, Lille
PrECOG, LLC.
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Merck Sharp & Dohme LLC